East Bridge Capital Master Fund on Thursday picked up more than 24 lakh shares worth around Rs 120 crore of Jubilant Life Sciences Ltd through an open market transaction.
According to the bulk deal data on BSE, a total of 24,05,583 shares were bought by East Bridge Capital Master Fund at an average price of Rs 497.6 apiece, valuing the transaction at Rs 119.7 crore.
In a separate transaction, Morgan Stanley Asia (Singapore) Pte sold 16,26,012 shares of Jubilant at an average price of Rs 495.75 apiece, valuing the transaction at Rs 80.6 crore.
According to the shareholding data for December 2019 quarter, both East Bridge Capital Master Fund and Morgan Stanley Asia (Singapore) Pte are public shareholders of Jubilant and held 4.63 per cent and 1.02 per cent stake, respectively, in the firm.
Jubilant Life Sciences shares closed at Rs 496.7, up 0.35 per cent, on BSE.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app